Literature DB >> 17496560

The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand.

Maria Xiridou1, Frits van Griensven, Jordan W Tappero, Michael Martin, Marc Gurwith, Suphak Vanichseni, Wanitchaya Kittikraisak, Roel Coutinho, Kachit Choopanya.   

Abstract

The HIV epidemic among injecting drug users (IDUs) in Bangkok was initially dominated by HIV subtype B and later by the recombinant CRF01_AE. The present study investigates the distribution of the 2 variants in time and how it is affected by changes in injecting risk behavior and treatment. A mathematic model describing the spread of HIV subtype B and CRF01_AE among IDUs was developed, and data from the AIDSVAX B/E cohort of IDUs in Bangkok were used. From the model, it was calculated that during 1999 to 2003, the annual incidence of HIV was around 0.6 and 2.7 to 3.9 infections per 100 person-years for subtype B and CRF01_AE, respectively. Of the new infections, 18% and 72% are first infections with subtype B and CRF01_AE, respectively, and 9% are superinfections. With increases in risk behavior, the fraction of superinfections rises. If treatment reduces the infectivity of CRF01_AE more than that of subtype B, the fraction of subtype B infections should increase. Subtype B should remain prevalent in a small but considerable fraction of the population for a long time. Changes in risk behavior and the introduction of treatment may alter the distribution of subtypes, but CRF01_AE should remain dominant.

Entities:  

Mesh:

Year:  2007        PMID: 17496560     DOI: 10.1097/QAI.0b013e318093dea5

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

Review 1.  Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

Authors:  Monica Vaccari; Poonam Poonam; Genoveffa Franchini
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

2.  Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.

Authors:  Wendy W Yeh; Pimkwan Jaru-Ampornpan; Daiva Nevidomskyte; Mohammed Asmal; Srinivas S Rao; Adam P Buzby; David C Montefiori; Bette T Korber; Norman L Letvin
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

3.  Increased genetic diversity of HIV-1 circulating in Hong Kong.

Authors:  Jonathan Hon-Kwan Chen; Ka-Hing Wong; Zhiwei Chen; Kenny Chan; Ho-Yin Lam; Sabrina Wai-Chi To; Vincent Chi-Chung Cheng; Kwok-Yung Yuen; Wing-Cheong Yam
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

4.  Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand.

Authors:  Marcos Pérez-Losada; David V Jobes; Faruk Sinangil; Keith A Crandall; Miguel Arenas; David Posada; Phillip W Berman
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

Review 5.  Identifying HIV-1 dual infections.

Authors:  Antoinette C van der Kuyl; Marion Cornelissen
Journal:  Retrovirology       Date:  2007-09-24       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.